Home Applications 219469 Application 219469
Type NDA
Sponsor BAYER HLTHCARE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LYNKUET ELINZANETANT CAPSULE;ORAL 60MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219469-001 LYNKUET ELINZANETANT 60MG CAPSULE / ORAL RLD, RS 2025-10-24
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219469-001 7683056 2027-09-15 Drug substance, Drug product 2025-11-13 N219469-001 10195205 2036-05-18 U-3622 2025-11-13 N219469-001 10774091 2039-03-13 Drug product 2025-11-13 N219469-001 11787820 2039-03-13 U-3622 2025-11-13 N219469-001 12264164 2039-03-13 U-3622 2025-11-13 N219469-001 12533358 2045-05-14 U-4402 2026-02-09
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219469-001 NCE 2030-10-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219469-001 LYNKUET 60MG CAPSULE / ORAL RLD, RS 2025-10-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 LYNKUET 60MG CAPSULE / ORAL RLD, RS 2025-10-24 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 LYNKUET 60MG CAPSULE / ORAL RLD, RS 2025-10-24 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219469-001 7683056 2026-09-15 Drug substance, Drug product 2025-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219469-001 10195205 2036-05-18 U-3622 2025-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219469-001 10774091 2039-03-13 Drug product 2025-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219469-001 11787820 2039-03-13 U-3622 2025-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219469-001 12264164 2039-03-13 U-3622 2025-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219469-001 12533358 2045-05-14 U-4402 2026-02-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 7683056 2026-09-15 Drug substance, Drug product 2025-11-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 10195205 2036-05-18 U-3622 2025-11-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 10774091 2039-03-13 Drug product 2025-11-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 11787820 2039-03-13 U-3622 2025-11-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 12264164 2039-03-13 U-3622 2025-11-13 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 7683056 2027-09-15 Drug substance, Drug product 2025-11-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 10195205 2036-05-18 U-3622 2025-11-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 10774091 2039-03-13 Drug product 2025-11-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 11787820 2039-03-13 U-3622 2025-11-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 12264164 2039-03-13 U-3622 2025-11-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 12533358 2045-05-14 U-4402 2026-02-09 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219469-001 NCE 2030-10-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219469-001 NCE 2030-10-24 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219469-001 NCE 2030-10-24 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join LYNKUET ELINZANETANT Bayer HealthCare Pharmaceuticals Inc. f42884ff-7dff-419c-8a0c-affe2ed73818 2026-03-04 Warnings, Adverse reactions Exact identifier application applno (NDA): 219469 application number: NDA219469
Documents# Document, Submission type, Date table Document Submission type Date 84353 ORIG 2025-12-08 83949 ORIG 2025-10-28 83920 ORIG 2025-10-27